Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› Suspension of availability of sertindole (Serdolect)
› Withdrawal of tolcapone (Tasmar)
› Astemizole (Hismanal): only available on prescription
› Rituximab (MabThera): serious infusion-related adverse reactions
› Reminder: Agranulocytosis with anti-thyroid drugs
› A new reporting initiative for paediatric adverse drug reactions in the Trent region
› Advice about adverse drug reaction reporting]
Current Problems in Pharmacovigilance February 1999 
